ETrade Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$461K Sell
4,742
-1,380
-23% -$159K 0.01% 586
2020
Q2
$751K Sell
6,122
-435
-7% -$49.4K 0.02% 436
2020
Q1
$574K Buy
+6,557
New +$694K 0.01% 436
2019
Q1
Sell
-2,101
Closed -$205K 875
2018
Q4
$205K Buy
+2,101
New +$276K 0.01% 714

Other funds holding GWPH

ETrade Capital Management's GWPH Position: Q3 2020 in Review

ETrade Capital Management reduced its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 23% in Q3 2020, selling an estimated $159K and leaving 4,742 shares worth $461K. The position accounts for 0.01% of the portfolio, ranked #586.

ETrade Capital Management first reported a position in GWPH in Q4 2018 and has held it in 4 quarters since. The position peaked at $751K in Q2 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

  • ETrade Capital Management held 4,742 shares of GW Pharmaceuticals Plc American Depositary Shares worth $461K as of Q3 2020.
  • ETrade Capital Management sold 1,380 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $159K.
  • GW Pharmaceuticals Plc American Depositary Shares made up 0.01% of ETrade Capital Management's portfolio in Q3 2020, its #586 holding.
  • ETrade Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and has held it in 4 quarters since.
  • ETrade Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $751K in Q2 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.